Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
Filetype[PDF-2.41 MB]


Details:
No Related Documents.
You May Also Like:
  1. Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
    Personal Author:
    Dizon, Don S.; Krilov, Lada; Cohen, Ezra; Gangadhar, Tara; Ganz, Patricia A.; Hensing, Thomas A.; Hunger, Stephen; Krishnamurthi, Smitha S.; Lassman, Andrew B.; Markham, Merry Jennifer; Mayer, Erica; Neuss, Michael; Pal, Sumanta Kumar; Richardson, Lisa C.; Schilsky, Richard; Schwartz, Gary K.; Spriggs, David R.; Villalona-Calero, Miguel Angel; Villani, Gina; Masters, Gregory;
    Published Date:
    Feb 04 2016
    Source:
    J Clin Oncol. 34(9):987-1011.
    File Type:
    Filetype[PDF - 692.37 KB]
  2. Wnt signaling in triple negative breast cancer is associated with metastasis
    Personal Author:
    Dey, Nandini; Barwick, Benjamin G; Moreno, Carlos S; Ordanic-Kodani, Maja; Chen, Zhengjia; Oprea-Ilies, Gabriella; Tang, Weining; Catzavelos, Charles; Kerstann, Kimberly F; Sledge, George W; Abramovitz, Mark; Bouzyk, Mark; De, Pradip; Leyland-Jones, Brian R;
    Published Date:
    Nov 10 2013
    Source:
    BMC Cancer. 2013; 13:537.
    Description:
    BackgroundTriple Negative subset of (TN) Breast Cancers (BC), a close associate of the basal-like subtype (with limited discordance) is an aggressive form of the disease which convey unpredictable, and poor prognosis due to limited treatment options ...
    File Type:
    Filetype[PDF - 1.82 MB]
  3. Safe Handling of Oral Antineoplastic Medications: Focus on Targeted Therapeutics in the Home Setting
    Personal Author:
    Cass, Yaakov; Connor, Thomas H.; Tabachnik, Alexander;
    Published Date:
    Mar 22 2016
    Source:
    J Oncol Pharm Pract. 23(5):350-378.
    Description:
    IntroductionWith the growing number of oral targeted therapies being approved for use in cancer therapy, the potential for long-term administration of these drugs to cancer patients is expanding. The use of these drugs in the home setting has the pot...
    File Type:
    Filetype[PDF - 448.42 KB]
  4. Combination of Protein Coding and Noncoding Gene Expression as a Robust Prognostic Classifier in Stage I Lung Adenocarcinoma
    Personal Author:
    Akagi, Ichiro; Okayama, Hirokazu; Schetter, Aaron J.; Robles, Ana I.; Kohno, Takashi; Bowman, Elise D.; Kazandjian, Dickran; Welsh, Judith A.; Oue, Naohide; Saito, Motonobu; Miyashita, Masao; Uchida, Eiji; Takizawa, Toshihiro; Takenoshita, Seiichi; Skaug, Vidar; Mollerup, Steen; Haugen, Aage; Yokota, Jun; Harris, Curtis C.;
    Published Date:
    May 02 2013
    Source:
    Cancer Res. 73(13):3821-3832
    Description:
    Prognostic tests for patients with early-stage lung cancer may provide needed guidance on postoperative surveillance and therapeutic decisions. We used a novel strategy to develop and validate a prognostic classifier for early-stage lung cancer. Spec...
    File Type:
    Filetype[PDF - 1.16 MB]
  5. HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia
    Personal Author:
    Akahane, Koshi; Sanda, Takaomi; Mansour, Marc R.; Radimerski, Thomas; DeAngelo, Daniel J.; Weinstock, David M.; Look, A. Thomas;
    Published Date:
    Aug 12 2015
    Source:
    Leukemia. 30(1):219-228.
    Description:
    We previously found that tyrosine kinase 2 (TYK2) signaling through its downstream effector phospho-STAT1 acts to upregulate BCL2, which in turn mediates aberrant survival of T-cell acute lymphoblastic leukemia (T-ALL) cells. Here we show that pharma...
    File Type:
    Filetype[PDF - 1.88 MB]